Biotechnology Stocks II Performance Guide: Mersana Therapeutics, Inc. (MRSN)
MRSN has no dividends.
Table and Chart of MRSN Performance
See what a $1,000 investment in MRSN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MRSN Returns | |
|---|---|
| Start Date | Jul-31-2017 |
| Start Price | $14.90 |
| End Date | May-16-2024 |
| End Price | $2.58 |
| # Prices | 83 |
| Min Date | Aug-31-2023 |
| Min Price | $1.11 |
| Max Date | Dec-31-2020 |
| Max Price | $26.61 |
| Total Return | -82.68% |
| Annualized Return | -22.39% |
| Current Value of $1,000 Purchase | $173 |
| Number Returns | 3,403 |
| Average Return | 7.93% |
| Number Profitable Returns | 1,067 |
| Percent Profitable Returns | 31.35% |
| Number Unprofitable Returns | 2,336 |
| Percent Unprofitable Returns | 68.65% |
| Profitable to Unprofitable Returns Ratio | 0.46 |
| MRSN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $301,620,000 |
| Beta | 1.591 | Price to Sales | 12.54 |
| Earnings per Share | $-1.1200 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 12.49 |
| PRICE DATA | |
| 52 Week High | $9.62 |
| 52 Week Low | $0.801 |
| Analyst Target Price | $6.57 |
| 50-Day Moving Average | $3.998 |
| 200-Day Moving Average | $2.556 |
| FINANCIAL DATA | |
| Revenue per Share | $0.32 |
| Revenue | $38,298,000 |
| Profit Margin | 0% |
| Return on Equity | -292.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MRSN Compare Returns with S&P 500
MRSN Trendline Chart
MRSN Moving Average Chart
MRSN Stock Return Map - See Patterns of Gains and Losses
MRSN Stock Returns/Purchase Dates